Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026)
Dr Reddys Laboratories' Current Assets was $3.1 billion in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 1.7% from $3.15 billion a year earlier and down 1.9% from the prior quarter.
Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Current Assets at Dr Reddys Laboratories came in at $3.22 billion, up 9.9% from FY2025.
- Current Assets shows a five-year compound annual growth rate of 9.7% (FY2021 to FY2026).
- In earlier fiscal years, Current Assets was $2.93 billion in FY2025 (-1.6%), $2.98 billion in FY2024 (+18.2%), $2.52 billion in FY2023 (+5.0%) and $2.4 billion in FY2022 (+18.3%).
- The fiscal Q2 2027 figure marks the lowest quarterly Current Assets since fiscal Q4 2025.
- Compared with a year earlier, Current Assets was higher in four of the last eight quarters, with growth averaging 3.1%.
- The best year-over-year quarter for Current Assets over five years was fiscal Q1 2025 (growth of 25.9%); the worst was fiscal Q1 2026 (a decline of 2.1%).
- Per Business Quant data, RDY's Current Assets in the three fiscal quarters before Q2 2027 was $3.16 billion (Q1 2027), $3.2 billion (Q4 2026) and $3.31 billion (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 3.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.10 Bn |
| Jun 30, 2026 | 3.16 Bn |
| Mar 31, 2026 | 3.20 Bn |
| Dec 31, 2025 | 3.31 Bn |
| Sep 30, 2025 | 3.15 Bn |
| Jun 30, 2025 | 3.16 Bn |
| Mar 31, 2025 | 2.92 Bn |
| Dec 31, 2024 | 2.95 Bn |
| Sep 30, 2024 | 2.96 Bn |
| Jun 30, 2024 | 3.23 Bn |
| Mar 31, 2024 | 2.97 Bn |
| Dec 31, 2023 | 2.90 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 2.56 Bn |
| Mar 31, 2023 | 2.49 Bn |
| Dec 31, 2022 | 2.35 Bn |
| Sep 30, 2022 | 2.16 Bn |
| Jun 30, 2022 | 2.28 Bn |
| Mar 31, 2022 | 2.40 Bn |
| Dec 31, 2021 | 2.24 Bn |
Dr Reddys Laboratories Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();